ArticleJournal of clinical microbiology2019
A Prospective Study of
Open access · bronzeAbstract read
In one paragraph
Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 30 citations in OpenAlex.
- DMEM and EMEM as alternate growth media for pathogenic Leptospira.PLoS neglected tropical diseases · 2026Article
- Altering Lipid A Precursor Ion Types in the Gas Phase for In-Depth Structural Elucidation via Tandem Mass Spectrometry.Analytical chemistry · 2025Article
- DMEM and EMEM are suitable surrogate media to mimic host environment and expand leptospiral pathogenesis studies usingbioRxiv : the preprint server for biology · 2025Article
- Sub-minimum inhibitory concentrations (sub-MICs) of colistin onMicrobiology spectrum · 2024Article
- Unsupervised learning and natural language processing highlight research trends in a superbug.Frontiers in artificial intelligence · 2024Article
- Structure Determination of Lipid A with Multiple Glycosylation Sites by Tandem MS of Lithium-Adducted Negative Ions.Journal of the American Society for Mass Spectrometry · 2023Article
- A Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Direct-from-Urine-Specimen Diagnostic for Gram-Negative Pathogens.Microbiology spectrum · 2022Article
- Constitutive Phenotypic Modification of Lipid A in Clinical Acinetobacter baumannii Isolates.Microbiology spectrum · 2022Article
- Rapid Antibiotic Susceptibility Testing by Deuterium Labeling of Bacterial Lipids in On-Target Microdroplet Cultures.Journal of the American Society for Mass Spectrometry · 2022Article
- The StkSR Two-Component System Influences Colistin Resistance inMicroorganisms · 2022Article
- A Novel Lipid-Based MALDI-TOF Assay for the Rapid Detection of Colistin-ResistantMicrobiology spectrum · 2022Article
- Colistin Treatment Affects Lipid Composition ofAntibiotics (Basel, Switzerland) · 2021Article
- Rapid microbial identification and colistin resistance detection via MALDI-TOF MS using a novel on-target extraction of membrane lipids.Scientific reports · 2020Article
- Cryo-EM structures of Acinetobacter baumannii glycerophospholipid transporter.Cell discovery · 2020Article
- MGMS2: Membrane glycolipid mass spectrum simulator for polymicrobial samples.Rapid communications in mass spectrometry : RCM · 2020Article
- Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.The Journal of antibiotics · 2020Article
- Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria.Science advances · 2020Article
- The clue is in the lipid A: Rapid detection of colistin resistance.PLoS pathogens · 2020Article
- The UDP-GalNAcA biosynthesis genes gna-gne2 are required to maintain cell envelope integrity and in vivo fitness in multi-drug resistant Acinetobacter baumannii.Molecular microbiology · 2020Article
- One System for All: Is Mass Spectrometry a Future Alternative for Conventional Antibiotic Susceptibility Testing?Frontiers in microbiology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 4 institutions in 2 countries.
Lisa M LeungDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA.ORCID 0000-0002-2014-6045
Christi L McElhenyDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Francesca M GardnerDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA.
Courtney E ChandlerDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA.
Sarah L BowlerDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Roberta T MettusDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Caressa N SpychalaDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Erin L FowlerDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Belita N A OpeneDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA.
Robert A MyersDivision of Microbiology, Laboratories Administration, Maryland Department of Health, Baltimore, Maryland, USA.
David R GoodlettDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Baltimore, Baltimore, Maryland, USA.
Yohei DoiDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA yod4@pitt.edu rkernst@umaryland.edu.
Robert K ErnstDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA yod4@pitt.edu rkernst@umaryland.edu.ORCID 0000-0001-5016-8694
University of Maryland, Baltimore · USUniversity of Pittsburgh · USFujita Health University · JPMaryland Department of Health · US
Funding
Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2MMS diagnostic bacterial identification libraryR01GM111066 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, GOODLETT, DAVID ROBINSON · 2014 to 2017
$1.2MStudy Network of Acinetobacter as a Carbapenem-Resistant Pathogen (SNAP)R21AI135522 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2018 to 2019
$460kMechanisms and implications of fosfomycin resistance in Escherichia coliR21AI123747 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2016 to 2017
$417kNIAID NIH HHS R01 AI104895NIAID NIH HHS R21 AI123747NIAID NIH HHS R21 AI135522NIGMS NIH HHS R01 GM111066
Abstract
PubMed holds no abstract for this paper.
Indexed as
Mass SpectrometryAcinetobacter baumanniiAnti-Bacterial AgentsCell MembraneColistinDrug Resistance, BacterialGlycolipidsMicrobial Sensitivity TestsProspective StudiesAnti-Bacterial AgentsColistinGlycolipidsAcinetobactercolistinlipid Amass spectrometry
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.